PatientsVille.com Logo

PatientsVille

Beyaz Side Effects

Common Beyaz Side Effects


The most commonly reported Beyaz side effects (click to view or check a box to report):

Pulmonary Embolism (162)
Deep Vein Thrombosis (111)
Pain (71)
Injury (54)
Emotional Distress (46)
Dyspnoea (38)
Anxiety (30)
Chest Pain (25)
Off Label Use (20)
Thrombosis (18)
Thrombophlebitis Superficial (18)
Metrorrhagia (17)
Pain In Extremity (17)
Headache (15)
No Adverse Event (15)
Nausea (13)
Menorrhagia (13)
Pelvic Venous Thrombosis (12)
Vaginal Haemorrhage (12)
Vomiting (12)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Beyaz Side Effects Reported to FDA

The following Beyaz reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Beyaz on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Acute Myocardial Infarction
This is a report of a 32-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Beyaz (dosage: NA, start time: NS), combined with:
  • Yasmin
and developed a serious reaction and side effect(s). The consumer presented with:
  • Acute Myocardial Infarction
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Beyaz treatment in female patients, resulting in acute myocardial infarction side effect. The patient was hospitalized.

Weight Increased
This report suggests a potential Beyaz Weight Increased side effect(s) that can have serious consequences. A 33-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: contraception and used Beyaz (dosage: Unk) starting NS. Soon after starting Beyaz the patient began experiencing various side effects, including:
  • Weight Increased
Drugs used concurrently: NA. Although Beyaz demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as weight increased, may still occur.

Ovulation Disorder, Menorrhagia, Night Sweats, Nightmare, Anger
This Ovulation Disorder, Menorrhagia, Night Sweats, Nightmare, Anger problem was reported by a health professional from US. A 33-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: premenstrual dysphoric disorder. On 201303 this consumer started treatment with Beyaz (dosage: Unk). The following drugs were being taken at the same time:
  • Portia-28
  • Seasonique (Unk)
  • Wellbatrin (300 Mg, Once)
  • Mvi [vitamins Nos] (Unk)
When commencing Beyaz, the patient experienced the following unwanted symptoms/side effects:
  • Ovulation Disorder
  • Menorrhagia
  • Night Sweats
  • Nightmare
  • Anger
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as ovulation disorder, may become evident only after a product is in use by the general population.

Thrombosis, Phlebitis, Deep Vein Thrombosis
This is a report of a 22-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: contraception and was treated with Beyaz (dosage: Unk) starting Jun 18, 2012. Concurrently used drugs:
  • Citalopram (40 Mg, Unk)
  • Tramadol (50 Mg, Unk)
  • Nabumetone
  • Keflex
  • Adderall (25 Mg, Unk)
  • Amphetamine Salts (10 Mg, Unk)
  • Albuterol (As Needed)
  • Trazodone (100 Mg, At Bedtime)
Soon after that, the consumer experienced the following side effects:
  • Thrombosis
  • Phlebitis
  • Deep Vein Thrombosis
This opens a possibility that Beyaz treatment could cause the above reactions, including thrombosis, and some female subjects may be more susceptible.


Rash, Urticaria, Lip Swelling
A 19-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Beyaz treatment (dosage: NA) on NS. Soon after starting Beyaz treatment, the subject experienced various side effects, including:
  • Rash
  • Urticaria
  • Lip Swelling
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Beyaz.

Pulmonary Embolism
A 43-year-old female patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Beyaz(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Pulmonary Embolism
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Beyaz efficacy: NA.The patient was hospitalized.

Skin Discolouration
In this report, Beyaz was administered for the following condition: menstrual cycle management.A 50-year-old female consumer from US (weight: NA) started Beyaz treatment (dosage: One Tablet Daily) on 201302.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Skin Discolouration
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Beyaz treatment could be related to the listed above side effect(s).

Thrombosis, Loss Of Consciousness, Cold Sweat, Skin Discolouration, Heart Rate Decreased, Pain In Extremity, Vomiting, Thoracic Haemorrhage
This is a report of the following Beyaz side effect(s):
  • Thrombosis
  • Loss Of Consciousness
  • Cold Sweat
  • Skin Discolouration
  • Heart Rate Decreased
  • Pain In Extremity
  • Vomiting
  • Thoracic Haemorrhage
A 18-year-old female patient from US (weight: NA) presented with the following condition: acne and received a treatment with Beyaz (dosage: Unk) starting: 201201.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Beyaz treatment could be associated with the listed above side effect(s).

Deep Vein Thrombosis, Vena Cava Thrombosis, Pulmonary Embolism, Injury, Pain, Emotional Distress
This Beyaz report was submitted by a 31-year-old female consumer from US (weight: NA). The patient was diagnosed with: NA and Beyaz was administered (dosage: Unk) starting: 201103. The consumer developed a set of symptoms:
  • Deep Vein Thrombosis
  • Vena Cava Thrombosis
  • Pulmonary Embolism
  • Injury
  • Pain
  • Emotional Distress
Other drugs used simultaneously:
  • Yasmin
  • Ibuprofen
The patient was hospitalized.Those unexpected symptoms could be linked to a Beyaz treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pulmonary Embolism
This is a report of a possible correlation between Beyaz use and the following symptoms/side effect(s):
  • Pulmonary Embolism
which could contribute to an assessment of Beyaz risk profile.A 39-year-old female consumer from US (weight: NA) was suffering from NA and was treated with Beyaz (dosage: NA) starting NS.Other concurrent medications:
  • Hydrochlorothiazide (25 Mg, Daily)
  • Multivitamin (1 Unk, Daily)
  • Remeron (15 Mg, Nightly)
  • Clotrimazole W/betamethasone Dipropionat
  • Proventil
  • Endocet
The patient was hospitalized.

Thrombosis, Pulmonary Embolism, Pain In Extremity, Vomiting, Unresponsive To Stimuli, Electroencephalogram Abnormal, Cardiac Failure, Pericardial Haemorrhage
A 18-year-old female patient from US (weight: NA) presented with the following symptoms: acne and after a treatment with Beyaz (dosage: 1 Daily Po) experienced the following side effect(s):
  • Thrombosis
  • Pulmonary Embolism
  • Pain In Extremity
  • Vomiting
  • Unresponsive To Stimuli
  • Electroencephalogram Abnormal
  • Cardiac Failure
  • Pericardial Haemorrhage
The treatment was started on Jan 01, 2012. Beyaz was used in combination with the following drugs: NA.This report could alert potential Beyaz consumers.

Deep Vein Thrombosis
In this report, a 23-year-old female patient from US (weight: NA) was affected by a possible Beyaz side effect.The patient was diagnosed with NA. After a treatment with Beyaz (dosage: NA, start date: Sep 23, 2011), the patient experienced the following side effect(s):
  • Deep Vein Thrombosis
The following simultaneously used drugs could have led to this reaction:
  • Ibuprofen (Unk)
  • Cefuroxime (Unk)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Beyaz treatment.

Pulmonary Embolism, Cardiac Arrest, Injury, Abdominal Pain, Emotional Distress, Anxiety, Deformity, Anhedonia, Fear Of Disease
This is a report of a 36-year-old female patient from US (weight: NA), who used Beyaz (dosage: Unk) for a treatment of NA. After starting a treatment on Feb 21, 2011, the patient experienced the following side effect(s):
  • Pulmonary Embolism
  • Cardiac Arrest
  • Injury
  • Abdominal Pain
  • Emotional Distress
  • Anxiety
  • Deformity
  • Anhedonia
  • Fear Of Disease
The following drugs could possibly have interacted with the Beyaz treatment NA.The patient was hospitalized and became disabled.Taken together, these observations suggest that a Beyaz treatment could be related to side effect(s), such as Pulmonary Embolism, Cardiac Arrest, Injury, Abdominal Pain, Emotional Distress, Anxiety, Deformity, Anhedonia, Fear Of Disease.

Gallbladder Disorder, Pain, Injury, Anxiety, Emotional Distress, Nephrolithiasis, Gastric Disorder, Biliary Dyskinesia
This gallbladder disorder side effect was reported by a consumer or non-health professional from US. A 16-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Beyaz (dosage: Unk), which was started on 2008. Concurrently used drugs:
  • Naprosyn (500 Mg,1 To 2 Times A Day As Needed)
  • Tamiflu (75 Mg, 1 To 2 Times A Day For 5 Days)
  • Omeprazole (40 Mg, Unk)
  • Tramadol
  • Zofran
When starting to take Beyaz the consumer reported the following symptoms:
  • Gallbladder Disorder
  • Pain
  • Injury
  • Anxiety
  • Emotional Distress
  • Nephrolithiasis
  • Gastric Disorder
  • Biliary Dyskinesia
The patient was hospitalized. These side effects may potentially be related to Beyaz.

Cholecystectomy, Biliary Dyskinesia, Injury, Pain, Emotional Distress
This is a Beyaz side effect report of a 19-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Beyaz (dosage:Unk, start time: 201106), combined with:
  • Ranitidine (150 Mg, Unk)
  • Ibuprofen
  • Miralax
, and developed a serious reaction and a cholecystectomy side effect. The patient presented with:
  • Cholecystectomy
  • Biliary Dyskinesia
  • Injury
  • Pain
  • Emotional Distress
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Beyaz treatment in female patients suffering from NA, resulting in cholecystectomy.

Gallbladder Injury, Cholecystitis Chronic, Pain, Emotional Distress
This report suggests a potential Beyaz gallbladder injury side effect(s) that can have serious consequences. A 20-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): NA and used Beyaz (dosage: Unk) starting 2007. Soon after starting Beyaz the patient began experiencing various side effects, including:
  • Gallbladder Injury
  • Cholecystitis Chronic
  • Pain
  • Emotional Distress
Drugs used concurrently:NA. Although Beyaz demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gallbladder injury, may still occur.

Vaginal Haemorrhage, Incorrect Dose Administered, Menorrhagia, Product Quality Issue
This vaginal haemorrhage problem was reported by a consumer or non-health professional from US. A 27-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): menstruation irregular.On NS a consumer started treatment with Beyaz (dosage: Unk). The following drugs/medications were being taken at the same time: NA. When commencing Beyaz, the patient experienced the following unwanted symptoms /side effects:
  • Vaginal Haemorrhage
  • Incorrect Dose Administered
  • Menorrhagia
  • Product Quality Issue
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as vaginal haemorrhage, may become evident only after a product is in use by the general population.

Pulmonary Embolism
This is a Beyaz side effect report of a 54-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: menstrual cycle management and was treated with Beyaz (dosage: NA) starting NS. Concurrently used drugs:
  • Aspirin
  • Vitamin D3
  • Fish Oil
  • Lisinopril
  • Metformin
  • Metoprolol
  • Omeprazole
  • Coenzyme Q10
Soon after that, the consumer experienced the following of symptoms:
  • Pulmonary Embolism
The patient was hospitalized. This opens a possibility that Beyaz could cause pulmonary embolism and that some female patients may be more susceptible.

Cerebrovascular Accident, Injury, Pain, Emotional Distress, Depression
A 28-year-old female patient (weight: NA) from US with the following symptoms: NA started Beyaz treatment (dosage: Unk) on May 03, 2011. Soon after starting Beyaz treatment, the consumer experienced several side effects, including:
  • Cerebrovascular Accident
  • Injury
  • Pain
  • Emotional Distress
  • Depression
. Concurrently used drugs:
  • Toradol
  • Compazine
  • Benadryl
  • Simvastatin (20 Mg, Daily)
  • Tramacet
  • Zocor
  • Zithromax
  • Diflucan
The patient was hospitalized and became disabled. This finding indicates that some patients can be more vulnerable to developing Beyaz side effects, such as cerebrovascular accident.

Pulmonary Embolism
This pulmonary embolism side effect was reported by a consumer or non-health professional from US. A 17-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Beyaz (dosage: NA), which was started on Dec 20, 2012. Concurrently used drugs:
  • Percocet
  • Hydrocodone W/apap (Unk)
  • Cyclobenzaprine (Unk)
.When starting to take Beyaz the consumer reported symptoms, such as:
  • Pulmonary Embolism
These side effects may potentially be related to Beyaz. The patient was hospitalized.

Intracranial Venous Sinus Thrombosis
This is a report of a 20-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Beyaz (dosage: NA, start time: NS), combined with:
  • Loestrin Fe
  • Dilantin
  • Fioricet
  • Keppra
and developed a serious reaction and side effect(s). The consumer presented with:
  • Intracranial Venous Sinus Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Beyaz treatment in female patients, resulting in intracranial venous sinus thrombosis side effect.

Intracranial Venous Sinus Thrombosis
This report suggests a potential Beyaz Intracranial Venous Sinus Thrombosis side effect(s) that can have serious consequences. A 20-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Beyaz (dosage: NA) starting NS. Soon after starting Beyaz the patient began experiencing various side effects, including:
  • Intracranial Venous Sinus Thrombosis
Drugs used concurrently:
  • Loestrin Fe
  • Dilantin
  • Fioricet
  • Keppra
  • Zocor
  • Gardasil
The patient was hospitalized. Although Beyaz demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as intracranial venous sinus thrombosis, may still occur.

Pulmonary Embolism
This Pulmonary Embolism problem was reported by a health professional from US. A 40-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: menorrhagia,premenstrual syndrome,skin disorder,ovulation pain. On NS this consumer started treatment with Beyaz (dosage: NA). The following drugs were being taken at the same time:
  • Yasmin
  • Yasmin
  • Yasmin
When commencing Beyaz, the patient experienced the following unwanted symptoms/side effects:
  • Pulmonary Embolism
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pulmonary embolism, may become evident only after a product is in use by the general population.

Thrombophlebitis Superficial
This is a report of a 21-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Beyaz (dosage: NA) starting Jun 08, 2011. Concurrently used drugs:
  • Ibuprofen [ibuprofen] (800 Mg, Unk)
  • Ibuprofen [ibuprofen] (800 Mg)
  • Ibuprofen [ibuprofen] (800 Mg, Unk)
  • Amoxicillin (500 Mg, Unk)
  • Amoxicillin (500 Mg, Unk)
  • Amoxicillin (500 Mg, Unk)
  • Naproxen (500 Mg, Unk)
  • Naproxen (500 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Thrombophlebitis Superficial
This opens a possibility that Beyaz treatment could cause the above reactions, including thrombophlebitis superficial, and some female subjects may be more susceptible.

Pulmonary Embolism, Dyspnoea, Tachycardia, Chest Pain
A 36-year-old female patient (weight: NA) from US with the following symptoms/conditions: contraception started Beyaz treatment (dosage: Unk Unk, Qd) on 2005. Soon after starting Beyaz treatment, the subject experienced various side effects, including:
  • Pulmonary Embolism
  • Dyspnoea
  • Tachycardia
  • Chest Pain
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Beyaz.

  5 of 19 



Top 10 Beyaz Side Effects for Women

Women Side EffectsReports
Pulmonary Embolism 162
Deep Vein Thrombosis 110
Pain 71
Injury 54
Emotional Distress 46
Dyspnoea 38
Anxiety 30
Chest Pain 25
Off Label Use 20
Thrombophlebitis Superficial 18

Top 10 Beyaz Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Beyaz Side Effects

    Did You Have a Beyaz Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Beyaz for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Beyaz Safety Alerts, Active Ingredients, Usage Information

    NDC50419-407
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameBeyaz
    NameDrospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
    Dosage FormKIT
    Route
    On market since20101007
    LabelerBayer HealthCare Pharmaceuticals Inc.
    Active Ingredient(s)
    Strength(s)
    Unit(s)
    Pharma Class

    More About Beyaz

    Side Effects reported to FDA: 465

    Beyaz safety alerts: No

    Reported deaths: 14

    Reported hospitalizations: 228

    Latest Beyaz clinical trials

    Beyaz Reviews

    No reviews, be a first to report a side effect via side effect reporting form